SIGA Technologies, Inc., is incorporated in Delaware. The company is a commercial-stage pharmaceutical company. The company sells its main product TPOXX to the US government and international governments. In addition, the company sells intravenous preparations of TPOXX to the US government. TPOXX is an oral antiviral drug used to treat human smallpox disease caused by smallpox virus. About IV TPOXX, SIGA Technologies, Inc., announced on May 19, 2022 that the FDA approved the formulation for the treatment of smallpox. In addition to FDA approval, oral TPOXX has regulatory approval from the European Medicines Agency, Health Canada and the UK Medicines and Healthcare Products Regulatory Agency. 

SIGA

SIGA Profile